XTX Topco Ltd Has $2.05 Million Stock Holdings in Haleon PLC Sponsored ADR (NYSE:HLN)

Key Points

• XTX Topco Ltd increased its stake in Haleon PLC by 33.4%, purchasing an additional 49,897 shares during the first quarter, bringing its total holdings to 199,348 shares.
• Several hedge funds, including Bartlett & CO. Wealth Management and Opal Wealth Advisors, made significant changes to their positions in Haleon during the first quarter, indicating increased institutional interest.
• Analysts have mixed ratings on Haleon, with Morgan Stanley upgrading its rating to "overweight" and a consensus average price target of $12.33.

XTX Topco Ltd grew its holdings in shares of Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) by 33.4% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 199,348 shares of the company's stock after purchasing an additional 49,897 shares during the period. XTX Topco Ltd's holdings in Haleon were worth $2,051,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in HLN. Allspring Global Investments Holdings LLC lifted its stake in Haleon by 6.1% during the first quarter. Allspring Global Investments Holdings LLC now owns 30,223 shares of the company's stock valued at $306,000 after buying an additional 1,749 shares in the last quarter. Oppenheimer & Co. Inc. lifted its stake in Haleon by 11.2% during the first quarter. Oppenheimer & Co. Inc. now owns 25,362 shares of the company's stock valued at $261,000 after buying an additional 2,564 shares in the last quarter. Concurrent Investment Advisors LLC lifted its stake in Haleon by 32.9% during the first quarter. Concurrent Investment Advisors LLC now owns 16,363 shares of the company's stock valued at $168,000 after buying an additional 4,055 shares in the last quarter. Mather Group LLC. lifted its stake in Haleon by 60.7% during the first quarter. Mather Group LLC. now owns 9,036 shares of the company's stock valued at $93,000 after buying an additional 3,413 shares in the last quarter. Finally, Farther Finance Advisors LLC lifted its stake in Haleon by 8.8% during the first quarter. Farther Finance Advisors LLC now owns 12,861 shares of the company's stock valued at $131,000 after buying an additional 1,041 shares in the last quarter. Institutional investors own 6.67% of the company's stock.

Wall Street Analyst Weigh In

HLN has been the subject of a number of research analyst reports. Wall Street Zen lowered shares of Haleon from a "buy" rating to a "hold" rating in a research report on Saturday, July 12th. Barclays reissued an "overweight" rating on shares of Haleon in a research report on Tuesday, May 6th. BNP Paribas raised shares of Haleon to a "strong-buy" rating in a research report on Tuesday, May 27th. Morgan Stanley raised shares of Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price target for the company in a research report on Friday, May 9th. Finally, BNP Paribas Exane raised shares of Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 price target for the company in a research report on Tuesday, May 27th. Six research analysts have rated the stock with a hold rating, four have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, Haleon presently has a consensus rating of "Moderate Buy" and a consensus price target of $12.33.

Haleon Stock Up 2.5%

NYSE:HLN traded up $0.24 during mid-day trading on Friday, reaching $9.67. The stock had a trading volume of 16,930,452 shares, compared to its average volume of 11,525,428. The business's 50 day moving average is $10.37 and its 200 day moving average is $10.18. Haleon PLC Sponsored ADR has a fifty-two week low of $8.86 and a fifty-two week high of $11.42. The stock has a market cap of $43.44 billion, a P/E ratio of 24.80, a PEG ratio of 2.73 and a beta of 0.23. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.98 and a quick ratio of 0.78.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.